1,2,3-benzotriazin-4-one: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 135408793 |
| CHEMBL ID | 3186681 |
| SCHEMBL ID | 169926 |
| MeSH ID | M0268129 |
| Synonym |
|---|
| AKOS005578809 |
| 1,2,3-benzotriazin-4(1h)-one |
| 1,2,3-benzotriazin-4(3h)-one |
| AB-323/25048510 |
| 4-ketobenz-1,2,3-triazine |
| 4-keto-(3h)-1,2,3-benzotriazine |
| benzoketotriazine |
| 1,2,3-benzotriazin-4-one |
| nsc 13563 |
| einecs 201-971-5 |
| 3h-1,2,3-benzotriazin-4-one |
| ai3-28017 |
| hsdb 5270 |
| nsc-20121 |
| benzazimide |
| 90-16-4 |
| 1,3-benzotriazin-4(3h)-one |
| 4-ketobenz-1,3-triazine |
| benzazimidone |
| usaf ma-2 |
| 1,3-benzotriazin-4(1h)-one |
| nsc-13563 |
| 1,3-benzotriazin-4-ol |
| 4-ketobenzotriazine |
| nsc13563 |
| nsc20121 |
| 1,2,3-benzotriazin-4-ol |
| 1,2,3-benzotriazin-4(3h)-one, 98% |
| inchi=1/c7h5n3o/c11-7-5-3-1-2-4-6(5)8-10-9-7/h1-4h,(h,8,9,11 |
| dmssttldfwkbsx-uhfffaoysa- |
| inchi=1/c7h5n3o/c11-7-5-3-1-2-4-6(5)8-10-9-7/h1-4h,(h,8,9,11) |
| 3,4,5-triazabicyclo[4.4.0]deca-3,6,8,10-tetraen-2-one |
| AKOS000489101 |
| 1h-1,2,3-benzotriazin-4-one |
| 3,4-dihydro-4-oxo-1,2,3-benzotriazine |
| 1,2,3-benzotriazine-4(3h)-one |
| K0003 |
| AKOS001042374 |
| A843459 |
| NCGC00249129-01 |
| dtxsid5026544 , |
| NCGC00256991-01 |
| cas-90-16-4 |
| dtxcid406544 |
| tox21_303160 |
| NCGC00259425-01 |
| tox21_201876 |
| 3,4-dihydro-1,2,3-benzotriazin-4-one |
| EN300-06440 |
| unii-fie1vty749 |
| fie1vty749 , |
| FT-0606216 |
| benzo[d][1,2,3]triazin-4(3h)-one |
| SCHEMBL169926 |
| 8M-907 |
| benzotriazinone |
| 1,2,3-benzotriazin-4(3h)one |
| 1,2.3-benzotriazin-4-(3h)-one |
| benzo-1,2,3-triazin-4-one |
| 4-ketobenztriazine |
| STR03758 |
| 1,2,3-benzotriazin-4(3h)one, |
| CHEMBL3186681 |
| mfcd00052387 |
| 4-ketobenzo-1,2,3(3h)-triazine |
| 1,2,3-benzotriazin-4-on |
| CS-0084775 |
| Q27278004 |
| 1,2,3-benzotriazin-4-(3h)one |
| F10403 |
| SY048922 |
| Z56943376 |
| Excerpt | Reference |
|---|---|
| " The enhanced inhibition of AChE observed with the TLS bioassay during the initial 30 min of photodegradation in case of all four OPs, confirmed the formation of toxic intermediates." | ( Photodegradation of organophosphorus insecticides - investigations of products and their toxicity using gas chromatography-mass spectrometry and AChE-thermal lens spectrometric bioassay. Bavcon Kralj, M; Franko, M; Trebse, P, 2007) |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| progesterone receptor | Homo sapiens (human) | Potency | 86.3492 | 0.0004 | 17.9460 | 75.1148 | AID1346795 |
| estrogen-related nuclear receptor alpha | Homo sapiens (human) | Potency | 0.6294 | 0.0015 | 30.6073 | 15,848.9004 | AID1224841 |
| estrogen nuclear receptor alpha | Homo sapiens (human) | Potency | 11.2875 | 0.0002 | 29.3054 | 16,493.5996 | AID743075 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | Homo sapiens (human) | Potency | 43.2771 | 0.0017 | 23.8393 | 78.1014 | AID743083 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||